Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Ovarian cancer

  • You have access
    Up-regulation of HDAC6 Results in Poor Prognosis and Chemoresistance in Patients With Advanced Ovarian High-grade Serous Carcinoma
    MITSUTAKE YANO, MARIKO MIYAZAWA, NAOKI OGANE, AIKO OGASAWARA, KOSEI HASEGAWA, HISASHI NARAHARA and MASANORI YASUDA
    Anticancer Research March 2021, 41 (3) 1647-1654; DOI: https://doi.org/10.21873/anticanres.14927
  • You have access
    YYB-101, a Humanized Antihepatocyte Growth Factor Monoclonal Antibody, Inhibits Ovarian Cancer Cell Motility and Proliferation
    HYUN JUNG KIM and KYUN HEO
    Anticancer Research February 2021, 41 (2) 671-678; DOI: https://doi.org/10.21873/anticanres.14818
  • You have access
    Relevance of Laparoscopic Surgery for Ovarian Cancer in Well-selected Patients: A Propensity-matched Comparison With Laparotomy
    FLORIANE JOCHUM, GABRIELLE AUBRY, MADELEINE PELLERIN, CAMILLE BILLARD, EMILIE FALLER, THOMAS BOISRAME, LISE LECOINTRE and CHERIF AKLADIOS
    Anticancer Research February 2021, 41 (2) 955-965; DOI: https://doi.org/10.21873/anticanres.14849
  • You have access
    The Prognostic Relevance of Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Gynecological Cancer
    ANGIOLO GADDUCCI and STEFANIA COSIO
    Anticancer Research January 2021, 41 (1) 9-20; DOI: https://doi.org/10.21873/anticanres.14747
  • You have access
    Hyperthermia During Intraperitoneal Chemotherapy With Paclitaxel or Docetaxel for Ovarian Cancer: Is There Any Benefit?
    EELCO DE BREE, DESPOINA KATSOUGKRI, HARA POLIOUDAKI, ELENA TSANGARIDOU, DIMOSTHENIS MICHELAKIS, ODYSSEAS ZORAS and PANAYIOTIS THEODOROPOULOS
    Anticancer Research December 2020, 40 (12) 6769-6780; DOI: https://doi.org/10.21873/anticanres.14700
  • You have access
    Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors
    MINNA SOPO, MAARIT ANTTILA, OONA-TUULI MUUKKONEN, SEPPO YLĂ„-HERTTUALA, VELI-MATTI KOSMA, LEEA KESKI-NISULA and HANNA SALLINEN
    Anticancer Research December 2020, 40 (12) 6923-6931; DOI: https://doi.org/10.21873/anticanres.14716
  • You have access
    Survival After Primary Surgery Compared With Neoadjuvant Chemotherapy in Early-stage Ovarian Cancer
    DEANNA HUFFMAN, RODNEY WEGNER, AMJAD JALIL, THOMAS KRIVAK and EIRWEN MILLER
    Anticancer Research November 2020, 40 (11) 6003-6008; DOI: https://doi.org/10.21873/anticanres.14621
  • You have access
    WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer
    SANGHOON LEE, JOHN JUN, WILLIAM J. KIM, PABLO TAMAYO and STEPHEN B. HOWELL
    Anticancer Research November 2020, 40 (11) 6017-6028; DOI: https://doi.org/10.21873/anticanres.14623
  • You have access
    Azidothymidine (AZT) Inhibits Proliferation of Human Ovarian Cancer Cells by Regulating Cell Cycle Progression
    YEUNTING HSIEH and JENN-JHY TSENG
    Anticancer Research October 2020, 40 (10) 5517-5527; DOI: https://doi.org/10.21873/anticanres.14564
  • You have access
    Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports
    SHU SOEDA, TAKAFUMI WATANABE, NORIHITO KAMO, TETSU SATO, CHIKAKO OKABE, MAKIKO UEDA, YUTA ENDO, KOJIMA MANABU, SHINJI NOMURA, SHIGENORI FURUKAWA, HIDEKAZU NISHIGORI, TOSHIFUMI TAKAHASHI and KEIYA FUJIMORI
    Anticancer Research September 2020, 40 (9) 5263-5270; DOI: https://doi.org/10.21873/anticanres.14530

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 14
Anticancer Research

© 2021 Anticancer Research

Powered by HighWire